Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hyperthyroidism I: Introduction

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...

Cushing Syndrome II: Pathophysiology

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...

Hyperthyroidism II: Pathophysiology

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...

Ovarian Cycle

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...

Oogenesis

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...

Disorders of the Female Reproductive System

Disorders of the Female Reproductive System

The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Metastatic Melanoma Presenting as Multiple Cardiac Masses: The Critical Role of Endomyocardial Biopsy.

JACC. Case reports·2025

Same author

Scurvy presenting in a homeless 32-year-old male: a case report.

European journal of clinical nutrition·2024

Same author

Left anterior descending artery disease in a 27-year-old with multiple endocrine neoplasia, type 2A: A case report.

SAGE open medical case reports·2023

Same author

Oral and Lower Extremity Ulcers as the Initial Presentation of Granulomatosis with Polyangiitis.

Case reports in medicine·2022

Same author

A Large Intrathoracic Hiatal Hernia as a Cause of Complete Heart Block.

Case reports in cardiology·2021

Same author

Vaping-Induced Lung Injury: A Case of Lipoid Pneumonia Associated with E-Cigarettes Containing Cannabis.

Case reports in pulmonology·2020

Search research articles

Related Experiment Video

Updated: May 27, 2026

X-Ray Visualization of Intraductal Ethanol-Based Ablative Treatment for Prevention of Breast Cancer in Rat Models

X-Ray Visualization of Intraductal Ethanol-Based Ablative Treatment for Prevention of Breast Cancer in Rat Models

Published on: December 9, 2022

Ovarian tumor-derived ectopic hyperprolactinemia.

Autumn F Elms¹, S J Carlan, Amy E Rich

¹Department of Obstetrics and Gynecology, Winnie Palmer Hospital, Orlando Regional Healthcare, 105 West Miller St, Orlando, FL 32806, USA.

|November 23, 2011

Summary

This summary is machine-generated.

Extreme hyperprolactinemia can arise from pituitary adenomas within ovarian dermoids, a rare cause of ectopic prolactin production. Surgical removal of the ovarian tumor is the definitive treatment for this endocrine dysfunction.

Related Experiment Videos

Last Updated: May 27, 2026

X-Ray Visualization of Intraductal Ethanol-Based Ablative Treatment for Prevention of Breast Cancer in Rat Models

X-Ray Visualization of Intraductal Ethanol-Based Ablative Treatment for Prevention of Breast Cancer in Rat Models

Published on: December 9, 2022

Area of Science:

Endocrinology
Gynecologic Oncology
Pathology

Background:

Ectopic prolactin production is a rare endocrine abnormality, occasionally associated with ovarian pathology.
Ovarian dermoid tumors, while benign, can exhibit unregulated endocrine activity.
Hyperprolactinemia from ovarian sources can lead to significant clinical symptoms.

Observation:

A unique case of extreme hyperprolactinemia was identified, originating from a pituitary adenoma within an ovarian dermoid cyst.
This represents the first reported instance of a pituitary tumor manifesting within an ovarian dermoid.
The adenoma within the dermoid was responsible for the profound elevation of serum prolactin levels.

Findings:

The study describes a novel presentation of hyperprolactinemia linked to an ovarian dermoid.
It highlights the potential for pituitary adenomas to develop ectopically within ovarian neoplasms.
Analysis of this case contributes to understanding the spectrum of ectopic prolactin secretion.

Implications:

Ectopic prolactin production should be considered in patients with unexplained hyperprolactinemia, especially when brain imaging is normal.
Surgical excision of the functioning ovarian tumor is crucial for resolving the hyperprolactinemia.
This case broadens the differential diagnosis for endocrine disorders originating outside the pituitary gland.